Ticamet (25 mcg+125 mcg)/puff (Inhaler)

120 metered doses: ৳ 596.79

Medicine Details

Category Details
Generic Salmeterol fluticasone propionate
Company Square pharmaceuticals plc
Also available as
Ticamet 25 mcg inhaler Ticamet 50 mcg inhalation capsule Ticamet 50 mcg inhalation capsule Ticamet 50 mcg inhalation capsule

Product Title

  • Ticamet Inhaler

Categories

  • Medicine
  • Asthma Treatment

Description

  • Combination product for regular treatment of asthma
  • Contains Salmeterol Xinafoate and Fluticasone Propionate
  • Available in inhaler and inhalation capsule forms
  • Administration through simple inhalation steps
  • Precautions and warnings for asthma and COPD patients
  • Therapeutic class: Long-acting selective β-adrenoceptor stimulants, Respiratory corticosteroids
  • Storage conditions: Store below 30°C, keep away from eyes and children

Color Options

  • N/A

Size Options

  • N/A

Dimensions

  • N/A

Material

  • Plastic
  • Metal canister

Technical Specifications

  • Salmeterol Xinafoate is a selective long-acting beta-2 agonist
  • Fluticasone Propionate has a potent glucocorticoid anti-inflammatory action within the lungs
  • Pressurised canister for inhaler
  • Rinsing the mouth after each inhalation is advised

Design Elements

  • Simple inhalation steps for effective use
  • Moulded plastic Maxhaler device
  • Foil strip with pre-dispensed inhalation powder
  • Patient friendly, ready to use and easy to grip inhaler device

Usability Features

  • Convenient regime for patients on concurrent β-agonist and inhaled corticosteroid therapy
  • Instructions for cleaning the inhaler included

Dosage

  • Different dosages for adults, adolescents, and children
  • Maximum recommended dosage for different age groups
  • Dosage based upon asthma severity
  • Use as per instructions for use

Indications

  • Regular treatment of asthma
  • Use in patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting β2-agonist or already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist

Interaction

  • Avoid non-selective and selective β-blockers in patients with asthma
  • Clinically significant drug interactions unlikely after inhaled dosing
  • Care should be taken when co-administering known strong CYP3A4 inhibitors

Contraindications

  • Patients with a history of hypersensitivity to salmeterol xinafoate, fluticasone propionate, or any of the excipients
  • Contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma

Side Effects

  • Tremor, subjective palpitations, headache, cardiac arrhythmia, hypersensitivity reactions, oropharyngeal irritation, muscle cramps
  • Hoarseness, candidiasis, cutaneous hypersensitivity reactions, facial and oropharyngeal edema

Pregnancy & Lactation

  • Consideration during pregnancy and lactation if the expected benefit to the mother is greater than any possible risk to the fetus or child
  • Insufficient experience in human pregnancy and lactation
  • Low concentrations in human breast milk supported by animal studies

Precautions & Warnings

  • Avoid initiation in patients during exacerbation or with unstable asthma
  • Continued treatment with medical advice if symptoms remain uncontrolled or worsen
  • Vigilance for the possible development of pneumonia in patients with COPD

Use in Special Populations

  • Orally inhaled corticosteroids may cause a reduction in growth velocity when administered to pediatric patients
  • Long-term effects of growth reduction are unknown

Overdose Effects

  • Signs and symptoms of overdose for Salmeterol and Fluticasone Propionate
  • Temporary suppression of adrenal function with acute overdose of Fluticasone Propionate
  • Chronic overdose of Fluticasone Propionate may lead to adrenal suppression

Maxhaler

  • Moulded plastic device containing a foil strip with pre-dispensed inhalation powder
  • Must be used daily for optimum benefit, even when asymptomatic

Indication in COPD

  • Increased reporting of pneumonia in studies of patients with COPD receiving salmeterol/fluticasone inhaler
  • No need to adjust the dose in elderly patients or those with renal impairment
  • No available data for hepatic impairment

Instructions for Cleaning Inhaler

  • Recommended to clean Inhaler at least once a week
  • Do not put the metal canister into water

Therapeutic Class

  • Long-acting selective β-adrenoceptor stimulants
  • Respiratory corticosteroids

Storage Conditions

  • Pressurised canister, do not puncture, break, or incinerate
  • Avoid storage in direct sunlight or heat

Related Brands